Patent Assignment
Reel/Frame 019390/0900
Assignment of Assignor's Interest
Recorded: 2007-06-04
Pages: 25
Assignor
PLATT, DAVID
Executed: 2001-03-27
Assignee
SAFESCIENCE, INC.
31 ST. JAMES AVE, BOSTON, MASSACHUSETTS, 02116
Covered Property
(1)
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Patent:
6,645,946 →
Application:
09/818,596 →
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jun 4, 2007
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 019365/0638 →
Assignment of Claims
Jun 4, 2007
From: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 019365/0510 →
Change of Name
Jun 4, 2007
From: SAFESCIENCE, INC.
To: GLYCOGENESYS, INC.
Reel/Frame 019365/0596 →
Change of Name
Jun 4, 2007
From: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
To: PROSPECT PHARMACEUTICALS, INC.
Reel/Frame 019365/0633 →
Court Appointment of Trustee
Jun 4, 2007
From: GLYCOGENESYS, INC.
To: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
Reel/Frame 019365/0501 →
Security Agreement
Aug 26, 2009
From: PRO-PHARMACEUTICALS, INC.
To: 10X FUND, LP
Reel/Frame 023134/0968 →
Change of Name
Oct 18, 2012
From: PRO-PHARMACEUTICALS, INC.
To: GALECTIN THERAPEUTICS INC.
Reel/Frame 029150/0654 →
Release of Security Interest
Sep 17, 2019
From: 10X FUND L.P.
To: GALECTIN THERAPEUTICS, INC.
Reel/Frame 050399/0679 →